[Treatment of malignant neoplasms in pregnancy. II].
Robak
T
T
Zakładu Farmakologii Klinicznej AM w Lodzi.
Drzewoski
J
J
D000014:Abnormalities, Drug-Induced; D000970:Antineoplastic Agents / Q000627:therapeutic use / Q000633:toxicity*; D002648:Child; D005260:Female; D005317:Fetal Growth Retardation / Q000139:chemically induced*; D005333:Fetus / Q000187:drug effects*; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy* / Q000601:surgery; D011297:Prenatal Exposure Delayed Effects
D000970:Antineoplastic Agents
Leczenie nowotworów w ciazy cz. II.